Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 23 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

1 of 15 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 1

5(38.5%)

Phase 2

3(23.1%)

Phase 4

2(15.4%)

Phase 3

2(15.4%)

N/A

1(7.7%)

13Total

Phase 1(5)

Phase 2(3)

Phase 4(2)

Phase 3(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials

NCT03057756Completed

Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance

Role: lead

NCT06212336Phase 2Recruiting

ISTH/ANRS 0409s INTEGRATE Lassa Fever Study

Role: collaborator

NCT07017803Not Yet Recruiting

Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region

Role: lead

NCT05905432Phase 1Completed

Pan-Malaria Transmission-Blocking Vaccine AnAPN1

Role: lead

NCT05222139Completed

Monitoring COVID-19 Vaccination Response in Fragile Populations

Role: collaborator

NCT03671109Phase 3Completed

Improving Maternal heAlth by Reducing Malaria in African HIV Women

Role: collaborator

NCT05303168Completed

Prevalence and Impact of COVID-19 on Maternal and Infant Health in African Populations

Role: collaborator

NCT05929157Phase 1Unknown

A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate

Role: lead

NCT04324853Completed

Helminth Infection During Pregnancy on Vitamin D Regulation: HELMVIT Study

Role: lead

NCT05865626Not ApplicableCompleted

Evaluation of the VOT Among Tuberculosis Patients From Lambaréné

Role: lead

NCT05130398Phase 1Completed

Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon

Role: lead

NCT05722054Unknown

Trained and Heterologous Induced-immune Responses to Tropical Infectious Diseases

Role: lead

NCT04847817Completed

Important Data on COVID-19 Profile in Africa

Role: lead

NCT04326868Phase 4Completed

Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in Gabon

Role: lead

NCT03779347Phase 3Unknown

Schistosomiasis Diagnosis Using a CAA Antigen Test

Role: lead

NCT03047642Completed

Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance Characteristics

Role: collaborator

NCT03373214Phase 1Completed

Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults

Role: collaborator

NCT04205669Phase 4Completed

Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon

Role: lead

NCT04505046Unknown

Validation of INSPiRED Innovative Smart Diagnostic Devices for the Detection of Parasites Infections.

Role: lead

NCT04264130Phase 2Completed

Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection

Role: lead